Discovery and Development of GS 4104 (oseltamivir) An Orally Active Influenza Neuraminidase Inhibitor

By  

Current Medicinal Chemistry, Vol. 7, Iss. 6, 2000-06 ,pp. : 663-672

Bentham Science Publishers

Access to resources Recommend Favorite

TC-2559: A novel orally active ligand selective at neuronal acetylcholine receptors

By Bencherif M.   Bane A.J.   Miller C.H.   Dull G.M.   Gatto G.J.  

European Journal of Pharmacology, Vol. 409, Iss. 1, 2000-12 ,pp. : 45-55

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics and Tolerability of the Orally Active Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 in Healthy Volunteers

By Swaisland H.  

Clinical Pharmacokinetics, Vol. 40, Iss. 4, 2001-01 ,pp. : 297-306

Adis International

Access to resources Recommend Favorite

Evaluation of WO2013116562A, an orally active PI3Kδ inhibitor for the treatment of asthma

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 5, 2014-05 ,pp. : 603-607

Informa Healthcare

Access to resources Recommend Favorite

Metabolism and Disposition of Pacritinib (SB1518), an Orally Active Janus Kinase 2 Inhibitor in Preclinical Species and Humans

By  

Drug Metabolism Letters, Vol. 9, Iss. 1, 2015-04 ,pp. : 28-47

Bentham Science Publishers

Access to resources Recommend Favorite